We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$67.4M
(+16%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
15.11%
Top 10 Holdings %
Top 10 Hldgs %
57.22%
Holding
53
New
11
Increased
11
Reduced
16
Closed
14
Top Buys
| 1 |
Procept Biorobotics
PRCT
|
+$43.2M |
| 2 |
Janux Therapeutics
JANX
|
+$35.9M |
| 3 |
Nektar Therapeutics
NKTR
|
+$31M |
| 4 |
Veeva Systems
VEEV
|
+$23.9M |
| 5 |
Phreesia
PHR
|
+$20.2M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$21.8M |
| 2 |
BridgeBio Pharma
BBIO
|
+$15.4M |
| 3 |
Roivant Sciences
ROIV
|
+$14M |
| 4 |
DexCom
DXCM
|
+$13.1M |
| 5 |
Immunovant
IMVT
|
+$10.1M |
Sector Composition
| 1 | Healthcare | 99.58% |
| 2 | Industrials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
26
Tectonic Therapeutic
TECX
$613M
| $4.9M | 1.01% |
235,000
-144,254
| -38% | -$2.68M |
|
27
CareDx
CDNA
$1.53B
| $4.71M | 0.97% |
250,000
-254,030
| -50% | -$4.26M |
|
|
TERN
28
DELISTED
Terns Pharmaceuticals
TERN
| $3.84M | 0.79% |
+95,000
| New | +$2.2M |
|
29
Rocket Pharmaceuticals
RCKT
$401M
| $2.61M | 0.54% |
743,942
-524,023
| -41% | -$1.79M |
|
30
OrthoPediatrics
KIDS
$508M
| $2.43M | 0.5% |
136,741
-171,966
| -56% | -$3.01M |
|
|
OKUR
31
OnKure Therapeutics
OKUR
$171M
| $2.37M | 0.49% |
816,909
+548,950
| +205% | +$1.64M |
|
|
32
BridgeBio Pharma
BBIO
$16.3B
| $2.29M | 0.47% |
30,000
-234,500
| -89% | -$15.4M |
|
|
ABVX
33
Abivax
ABVX
$11.8B
| $2.29M | 0.47% |
+17,000
| New | +$1.85M |
|
34
Adicet Bio
ACET
$81.3M
| $2.11M | 0.44% |
+250,244
| New | +$2.77M |
|
|
TEM
35
Tempus AI
TEM
$10.3B
| $2.07M | 0.43% |
+35,000
| New | +$2.74M |
|
|
TBI
36
Trueblue
TBI
$251M
| $2.01M | 0.42% |
442,554
+363,078
| +457% | +$1.86M |
|
37
Pliant Therapeutics
PLRX
$68.7M
| $1.9M | 0.39% |
1,555,744
+1,535,257
| +7,494% | +$2.31M |
|
|
RNTX
38
Rein Therapeutics
RNTX
$80.5M
| $513K | 0.11% |
442,600
-125,298
| -22% | -$173K |
|
39
Acadia Healthcare
ACHC
$3B
| – | – |
-250,000
| Closed | -$6.19M |
|
|
AKRO
40
DELISTED
Akero Therapeutics
AKRO
| – | – |
-39,072
| Closed | -$1.86M |
|
41
Align Technology
ALGN
$12.9B
| – | – |
-19,442
| Closed | -$2.43M |
|
42
argenx
ARGX
$54.2B
| – | – |
-3,300
| Closed | -$2.43M |
|
43
Biohaven
BHVN
$2.25B
| – | – |
-600,000
| Closed | -$9.01M |
|
44
Corcept Therapeutics
CORT
$9.59B
| – | – |
0
| – | – |
|
45
CytomX Therapeutics
CTMX
$799M
| – | – |
-564,800
| Closed | -$1.8M |
|
|
46
DexCom
DXCM
$28.5B
| – | – |
-195,217
| Closed | -$13.1M |
|
|
47
Intuitive Surgical
ISRG
$138B
| – | – |
-48,711
| Closed | -$21.8M |
|
48
Prothena Corp
PRTA
$450M
| – | – |
-20,000
| Closed | -$195K |
|
49
Schrodinger
SDGR
$1.22B
| – | – |
-34,830
| Closed | -$699K |
|
50
Sight Sciences
SGHT
$283M
| – | – |
-439,941
| Closed | -$1.51M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA